This company listing is no longer active
Acasti Pharma Beheer
Beheer criteriumcontroles 0/4
Belangrijke informatie
Jan D'Alvise
Algemeen directeur
US$1.8m
Totale compensatie
Percentage CEO-salaris | 25.1% |
Dienstverband CEO | 6.8yrs |
Eigendom CEO | 0.01% |
Management gemiddelde ambtstermijn | 1.6yrs |
Gemiddelde ambtstermijn bestuur | 1.4yrs |
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Dec 31 2022 | n/a | n/a | -US$17m |
Sep 30 2022 | n/a | n/a | -US$17m |
Jun 30 2022 | n/a | n/a | -US$11m |
Mar 31 2022 | US$2m | US$445k | -US$10m |
Dec 31 2021 | n/a | n/a | -US$12m |
Sep 30 2021 | n/a | n/a | -US$11m |
Jun 30 2021 | n/a | n/a | -US$18m |
Mar 31 2021 | US$582k | US$428k | -US$20m |
Dec 31 2020 | n/a | n/a | US$3m |
Sep 30 2020 | n/a | n/a | -US$6m |
Jun 30 2020 | n/a | n/a | -US$21m |
Mar 31 2020 | US$2m | US$411k | -US$26m |
Dec 31 2019 | n/a | n/a | -US$56m |
Sep 30 2019 | n/a | n/a | -US$46m |
Jun 30 2019 | n/a | n/a | -US$42m |
Mar 31 2019 | US$926k | US$373k | -US$39m |
Dec 31 2018 | n/a | n/a | -US$31m |
Sep 30 2018 | n/a | n/a | -US$34m |
Jun 30 2018 | n/a | n/a | -US$20m |
Mar 31 2018 | US$891k | US$337k | -US$17m |
Mar 31 2017 | US$631k | US$275k | -US$8m |
Compensatie versus markt: Jan's total compensation ($USD1.77M) is above average for companies of similar size in the Canadian market ($USD172.33K).
Compensatie versus inkomsten: Jan's compensation has increased whilst the company is unprofitable.
CEO
Jan D'Alvise (67 yo)
6.8yrs
Tenure
US$1,773,841
Compensatie
Ms. Janelle D’Alvise, also known as Jan, has been an Independent Director of Spectral Medical Inc. since June 03, 2021. She is the Chairman of the board of The ObG Project. She has been the Chief Executive...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 6.8yrs | US$1.77m | 0.015% CA$ 2.8k | |
Co-Founder | 12.9yrs | US$905.45k | 0.0020% CA$ 377.0 | |
Chief Financial Officer | 2.5yrs | US$847.55k | 0% CA$ 0 | |
Chief Operating Officer of US | 1.6yrs | US$666.86k | 0% CA$ 0 | |
Chief Commercial Officer | 1.2yrs | US$403.62k | 0.29% CA$ 55.2k | |
Vice President of Quality & Compliance | 1.5yrs | geen gegevens | geen gegevens | |
Senior Director of Human Resources | 1.2yrs | geen gegevens | geen gegevens |
1.6yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: ACST's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 6.7yrs | US$1.77m | 0.015% CA$ 2.8k | |
Independent Director | 4.9yrs | US$131.60k | 0.011% CA$ 2.0k | |
Independent Director | less than a year | US$6.00k | geen gegevens | |
Independent Director | 6.7yrs | US$134.10k | 0.028% CA$ 5.4k | |
Member of Scientific Advisory Board | less than a year | geen gegevens | geen gegevens | |
Independent Director | 1.6yrs | US$96.60k | 0% CA$ 0 | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | less than a year | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 1.2yrs | geen gegevens | geen gegevens |
1.4yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: ACST's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.